3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
5
Recurrence
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Waldenstrom Macroglobulinemia
2
Lymphoma, Mantle-Cell
2
Lymphoma
2
Leukemia
2
B-cell Malignancies
2
Lymphoma, B-Cell
1
Interventions
Rituximab
9
Whole-Body Irradiation
7
Peripheral Blood Stem Cell Transplantation
7
fludarabine phosphate
6
Cyclophosphamide
6
Etoposide
5
Tacrolimus
4
Mycophenolic Acid
4
Cyclosporine
4
Carboplatin
4
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Busulfan
3
Thiotepa
2
Melphalan
2
Lenalidomide
2
Ipilimumab
2
Dexamethasone
2
Calcium Dobesilate
2
CTLA-4 Antigen
2
Bendamustine Hydrochloride
2
Antilymphocyte Serum
2
veliparib
1
sodium thiosulfate
1
pegfilgrastim
1
oblimersen
1
merphos
1
etoposide phosphate
1
Vorinostat
1
Vincristine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Intraocular Lymphoma
×
zanubrutinib
×
Clear all
No trials found.